CANCER VACCINE AND METHOD OF USE THEREOF Read more about CANCER VACCINE AND METHOD OF USE THEREOF US Application 18/550,895Filed on 2023-09-15
IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OFCANCER AND MYELOID-MEDIATED DISEASES Read more about IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OFCANCER AND MYELOID-MEDIATED DISEASES Patent Cooperation TreatyPCT/US2023/078854Filed on 2023-11-06
T CELL RECEPTORS RECOGNIZING MUTATED P53 Read more about T CELL RECEPTORS RECOGNIZING MUTATED P53 Eurasian Patent202392526Filed on 2023-10-06
Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs Read more about Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs Switzerland16725323.6Filed on 2016-05-13
Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs Read more about Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs United Kingdom16725323.6Filed on 2016-05-13
Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs Read more about Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs Germany16725323.6Filed on 2016-05-13
Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs Read more about Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs France16725323.6Filed on 2016-05-13
Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs Read more about Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs Spain16725323.6Filed on 2016-05-13
HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION Patent Cooperation TreatyPCT/US2023/078156Filed on 2023-10-30
Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors Read more about Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors European Patent22738126.6Filed on 2023-10-18